162 related articles for article (PubMed ID: 17721272)
1. p16INK4a expression in invasive vulvar squamous cell carcinoma.
Tringler B; Grimm C; Dudek G; Zeillinger R; Tempfer C; Speiser P; Joura E; Reinthaller A; Hefler LA
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):279-83. PubMed ID: 17721272
[TBL] [Abstract][Full Text] [Related]
2. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.
Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J
Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277
[TBL] [Abstract][Full Text] [Related]
3. Squamous Cell Carcinoma of the Vulva: A Subclassification of 97 Cases by Clinicopathologic, Immunohistochemical, and Molecular Features (p16, p53, and EGFR).
Dong F; Kojiro S; Borger DR; Growdon WB; Oliva E
Am J Surg Pathol; 2015 Aug; 39(8):1045-53. PubMed ID: 26171917
[TBL] [Abstract][Full Text] [Related]
4. p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas.
Knopp S; Bjørge T; Nesland JM; Tropé C; Scheistrøen M; Holm R
Gynecol Oncol; 2004 Oct; 95(1):37-45. PubMed ID: 15385108
[TBL] [Abstract][Full Text] [Related]
5. Fascin and cyclin D1 immunoreactivity in non-neoplastic vulvar squamous epithelium, vulvar intraepithelial neoplasia and invasive squamous carcinoma: correlation with Ki67 and p16 protein expression.
Stewart CJ; Crook ML
J Clin Pathol; 2014 Apr; 67(4):319-25. PubMed ID: 24218024
[TBL] [Abstract][Full Text] [Related]
6. The etiologic role of HPV in vulvar squamous cell carcinoma fine tuned.
van de Nieuwenhof HP; van Kempen LC; de Hullu JA; Bekkers RL; Bulten J; Melchers WJ; Massuger LF
Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2061-7. PubMed ID: 19567503
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of thrombospondin-1 in invasive vulvar squamous cell carcinoma.
Tringler B; Grimm C; Sliutz G; Leodolter S; Speiser P; Reinthaller A; Hefler LA
Gynecol Oncol; 2005 Oct; 99(1):80-3. PubMed ID: 16009408
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Significance of Human Papilloma Virus and p16 Expression in Patients with Vulvar Squamous Cell Carcinoma who Received Radiotherapy.
Yap ML; Allo G; Cuartero J; Pintilie M; Kamel-Reid S; Murphy J; Mackay H; Clarke B; Fyles A; Milosevic M
Clin Oncol (R Coll Radiol); 2018 Apr; 30(4):254-261. PubMed ID: 29449057
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers p16, Human Papillomavirus and p53 Predict Recurrence and Survival in Early Stage Squamous Cell Carcinoma of the Vulva.
Hay CM; Lachance JA; Lucas FL; Smith KA; Jones MA
J Low Genit Tract Dis; 2016 Jul; 20(3):252-6. PubMed ID: 26855143
[TBL] [Abstract][Full Text] [Related]
10. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
[TBL] [Abstract][Full Text] [Related]
11. Research on expression and importance of p53, p16 and VEGF-C in cervical cancer.
Cai S; Han K
J Gynecol Obstet Biol Reprod (Paris); 2015 Sep; 44(7):639-45. PubMed ID: 25443468
[TBL] [Abstract][Full Text] [Related]
12. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.
Lérias S; Esteves S; Silva F; Cunha M; Cochicho D; Martins L; Félix A
Mod Pathol; 2020 May; 33(5):893-904. PubMed ID: 31844270
[TBL] [Abstract][Full Text] [Related]
13.
Lozar T; Keske A; Dube Mandishora RS; Yu Q; Bailey A; Xu J; Tommasino M; McGregor SM; Lambert PF; Gheit T; Fitzpatrick MB
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766356
[TBL] [Abstract][Full Text] [Related]
14. The impact of p16
Gensthaler L; Joura EA; Alemany L; Horvat R; de Sanjosé S; Pils S
Arch Gynecol Obstet; 2020 Mar; 301(3):753-759. PubMed ID: 31970493
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
Ivanova TA; Golovina DA; Zavalishina LE; Volgareva GM; Katargin AN; Andreeva YY; Frank GA; Kisseljov FL; Kisseljova NP
BMC Cancer; 2007 Mar; 7():47. PubMed ID: 17359536
[TBL] [Abstract][Full Text] [Related]
16. Expression of p15INK⁴b and p57KIP² and relationship with clinicopathological features and prognosis in patients with vulvar squamous cell carcinoma.
Holm R; Førsund M; Nguyen MT; Nesland JM; Trope CG
PLoS One; 2013; 8(4):e61273. PubMed ID: 23580324
[TBL] [Abstract][Full Text] [Related]
17. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
Suzuki H; Sugimura H; Hashimoto K
J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
[TBL] [Abstract][Full Text] [Related]
18. Local immune response depends on p16INK4a status of primary tumor in vulvar squamous cell carcinoma.
Sznurkowski JJ; Żawrocki A; Biernat W
Oncotarget; 2017 Jul; 8(28):46204-46210. PubMed ID: 28515351
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of overexpressed p16(INK4A) in esophageal squamous cell carcinoma: a meta-analysis.
Wang L; Li J; Yu X; Zhang Z; Pang L; Li S; Hou J; Li F
Biomark Med; 2016 May; 10(5):537-46. PubMed ID: 27071776
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of E2F-1 is associated with increased disease-free survival in squamous cell carcinoma of the anterior tongue.
Kwong RA; Nguyen TV; Bova RJ; Kench JG; Cole IE; Musgrove EA; Henshall SM; Sutherland RL
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3705-11. PubMed ID: 14506162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
